动脉高血压--临床试验更新 2024

IF 4.3 2区医学 Q1 PERIPHERAL VASCULAR DISEASE Hypertension Research Pub Date : 2024-09-19 DOI:10.1038/s41440-024-01900-7

Mert Tokcan, Lucas Lauder, Felix Götzinger, Michael Böhm, Felix Mahfoud

{"title":"动脉高血压--临床试验更新 2024","authors":"Mert Tokcan, Lucas Lauder, Felix Götzinger, Michael Böhm, Felix Mahfoud","doi":"10.1038/s41440-024-01900-7","DOIUrl":null,"url":null,"abstract":"Arterial hypertension remains the most important modifiable cardiovascular risk factor for morbidity and mortality worldwide. This review summarizes and discusses major clinical trials published in 2023 and early 2024 in hypertension research. These trials include new epidemiological data, studies investigating the impact of blood pressure cuff size on blood pressure measurements, benefits of salt substitutes, and novel antihypertensive treatment options, including pharmacotherapy and bariatric surgery in patients with obesity. This summary reviews the major clinical trials published in 2023 and early 2024. AHT – arterial hypertension, BP – blood pressure, HR – hazard ratio, OBP – office blood pressure, PRA – plasma renin activity, SBP – systolic blood pressure.","PeriodicalId":13029,"journal":{"name":"Hypertension Research","volume":null,"pages":null},"PeriodicalIF":4.3000,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.nature.com/articles/s41440-024-01900-7.pdf","citationCount":"0","resultStr":"{\"title\":\"Arterial hypertension—clinical trials update 2024\",\"authors\":\"Mert Tokcan, Lucas Lauder, Felix Götzinger, Michael Böhm, Felix Mahfoud\",\"doi\":\"10.1038/s41440-024-01900-7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Arterial hypertension remains the most important modifiable cardiovascular risk factor for morbidity and mortality worldwide. This review summarizes and discusses major clinical trials published in 2023 and early 2024 in hypertension research. These trials include new epidemiological data, studies investigating the impact of blood pressure cuff size on blood pressure measurements, benefits of salt substitutes, and novel antihypertensive treatment options, including pharmacotherapy and bariatric surgery in patients with obesity. This summary reviews the major clinical trials published in 2023 and early 2024. AHT – arterial hypertension, BP – blood pressure, HR – hazard ratio, OBP – office blood pressure, PRA – plasma renin activity, SBP – systolic blood pressure.\",\"PeriodicalId\":13029,\"journal\":{\"name\":\"Hypertension Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2024-09-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.nature.com/articles/s41440-024-01900-7.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hypertension Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.nature.com/articles/s41440-024-01900-7\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hypertension Research","FirstCategoryId":"3","ListUrlMain":"https://www.nature.com/articles/s41440-024-01900-7","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}

引用次数: 0

摘要

动脉高血压仍然是全球发病率和死亡率中最重要的可改变的心血管风险因素。本综述总结并讨论了 2023 年和 2024 年初在高血压研究领域发表的主要临床试验。这些试验包括新的流行病学数据、调查血压袖带尺寸对血压测量影响的研究、盐替代品的益处以及新型降压治疗方案，包括肥胖症患者的药物治疗和减肥手术。AHT 动脉高血压、BP 血压、HR 危险比、OBP 办公室血压、PRA 血浆肾素活性、SBP 收缩压。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

摘要图片

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Arterial hypertension—clinical trials update 2024

Arterial hypertension remains the most important modifiable cardiovascular risk factor for morbidity and mortality worldwide. This review summarizes and discusses major clinical trials published in 2023 and early 2024 in hypertension research. These trials include new epidemiological data, studies investigating the impact of blood pressure cuff size on blood pressure measurements, benefits of salt substitutes, and novel antihypertensive treatment options, including pharmacotherapy and bariatric surgery in patients with obesity. This summary reviews the major clinical trials published in 2023 and early 2024. AHT – arterial hypertension, BP – blood pressure, HR – hazard ratio, OBP – office blood pressure, PRA – plasma renin activity, SBP – systolic blood pressure.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Hypertension Research 医学-外周血管病

CiteScore

7.40

自引率

16.70%

发文量

249

审稿时长

3-8 weeks

期刊介绍： Hypertension Research is the official publication of the Japanese Society of Hypertension. The journal publishes papers reporting original clinical and experimental research that contribute to the advancement of knowledge in the field of hypertension and related cardiovascular diseases. The journal publishes Review Articles, Articles, Correspondence and Comments.